Published in Curr Atheroscler Rep on September 01, 2013
Modeling health gains and cost savings for ten dietary salt reduction targets. Nutr J (2016) 0.81
The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects. BMC Public Health (2016) 0.78
A systematic review of economic evaluations of population-based sodium reduction interventions. PLoS One (2017) 0.78
Estimation of salt intake assessed by urinary excretion of sodium over 24 h in Spanish subjects aged 7-11 years. Eur J Nutr (2015) 0.77
Effects of a Stroke Primary Prevention Program on Risk Factors for At-Home Elderly. Med Sci Monit (2015) 0.75
Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 49.95
The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon) (2003) 34.28
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med (2010) 12.04
Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA (2011) 8.83
Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet (2007) 6.45
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ (2009) 6.23
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet (2003) 5.17
Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med (2010) 5.14
Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68
Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet (2011) 4.37
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ (2011) 3.86
Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J (2006) 3.65
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14
Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens (2011) 2.97
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89
Mortality benefits from US population-wide reduction in sodium consumption: projections from 3 modeling approaches. Hypertension (2013) 2.41
Cost of cardiovascular diseases in the United Kingdom. Heart (2006) 1.70
Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke (2012) 1.65
Potential societal savings from reduced sodium consumption in the U.S. adult population. Am J Health Promot (2009) 1.53
The cost-effectiveness of interventions designed to reduce sodium intake. J Hypertens (2011) 1.36
Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol (2011) 1.35
Potential health benefits and medical cost savings from calorie, sodium, and saturated fat reductions in the American diet. Am J Health Promot (2009) 1.34
The use of QALYs in clinical and patient decision-making: issues and prospects. Value Health (2009) 1.32
Dietary sodium intake and cardiovascular mortality: controversy resolved? Am J Hypertens (2012) 1.27
Which interventions offer best value for money in primary prevention of cardiovascular disease? PLoS One (2012) 1.15
Review of Australian health economic evaluation - 245 interventions: what can we say about cost effectiveness? Cost Eff Resour Alloc (2008) 1.14
The economics of primary prevention of cardiovascular disease - a systematic review of economic evaluations. Cost Eff Resour Alloc (2007) 1.08
Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina. Cost Eff Resour Alloc (2009) 1.02
Reducing salt intake to prevent hypertension and cardiovascular disease. Rev Panam Salud Publica (2012) 1.02
Cost-effectiveness analysis of interventions to prevent cardiovascular disease in Vietnam. Health Policy Plan (2010) 1.01
Population-wide sodium reduction: the bumpy road from evidence to policy. Ann Epidemiol (2012) 0.99
Predicted national productivity implications of calorie and sodium reductions in the American diet. Am J Health Promot (2009) 0.96
Estimating the potential health impact and costs of implementing a local policy for food procurement to reduce the consumption of sodium in the county of Los Angeles. Am J Public Health (2011) 0.92
Sodium intake and cardiovascular disease. Annu Rev Public Health (2011) 0.85
Health economic consequences of reducing salt intake and replacing saturated fat with polyunsaturated fat in the adult Finnish population: estimates based on the FINRISK and FINDIET studies. Eur J Clin Nutr (2011) 0.84
[The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina]. Rev Panam Salud Publica (2012) 0.82
Is salt intake an independent risk factor of stroke mortality? Demographic analysis by regions in Japan. J Am Soc Hypertens (2011) 0.80
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 25.44
Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr (2002) 7.34
Primary prevention of type 2 diabetes mellitus by lifestyle intervention: implications for health policy. Ann Intern Med (2004) 1.79
Community-based lifestyle interventions to prevent type 2 diabetes. Diabetes Care (2003) 1.70
Intraindividual variation in serum retinol concentrations among participants in the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr (2004) 1.41
Laboratory issues: use of nutritional biomarkers. J Nutr (2003) 1.19
Changes in health behaviors among older Americans, 1990 to 2000. Public Health Rep (2004) 1.14
Assessment of infant feeding: the validity of measuring milk intake. Nutr Rev (2002) 1.02
Vitamin or supplement use among adults, behavioral risk factor surveillance system, 13 states, 2001. Public Health Rep (2005) 0.99
Differences in the relation of obesity to serum triacylglycerol and VLDL subclass concentrations between black and white children: the Bogalusa Heart Study. Am J Clin Nutr (2002) 0.98
Sodium reduction is a public health priority: reflections on the Institute of Medicine's report, sodium intake in populations: assessment of evidence. Am J Hypertens (2013) 0.96
Use of Urine Biomarkers to Assess Sodium Intake: Challenges and Opportunities. Annu Rev Nutr (2015) 0.93
Angular stomatitis and riboflavin status among adolescent Bhutanese refugees living in southeastern Nepal. Am J Clin Nutr (2002) 0.93
HFE genotype and transferrin saturation in the United States. Genet Med (2003) 0.91
Toward prevention and control of type 2 diabetes: challenges at the U.S.-Mexico border and beyond. Prev Chronic Dis (2004) 0.86
Obesity and endometrial cancer: challenges for public health action. Womens Health (Lond Engl) (2009) 0.84
Learning from listening: common concerns and perceptions about diabetes prevention among diverse American populations. J Public Health Manag Pract (2003) 0.83
Economic analysis of nutrition interventions for chronic disease prevention: methods, research, and policy. Nutr Rev (2011) 0.82
Vital signs: sodium intake among U.S. school-aged children - 2009-2010. MMWR Morb Mortal Wkly Rep (2014) 0.81
Are persons with diabetes practicing healthier behaviors in the year 2001? Results from the Behavioral Risk Factor Surveillance System. Prev Med (2004) 0.81
Vital Signs: Predicted Heart Age and Racial Disparities in Heart Age Among U.S. Adults at the State Level. MMWR Morb Mortal Wkly Rep (2015) 0.78
Thiamine deficiency, beriberi, and maternal and child health: why pharmacokinetics matter. Am J Clin Nutr (2013) 0.78
The knowledge-action gap in diabetes. Nutr Clin Care (2003) 0.76
Sodium reduction: an important public health strategy for heart health. J Public Health Manag Pract (2013) 0.75
Conflict of interest policy for Editors of The American Journal of Clinical Nutrition. Am J Clin Nutr (2007) 0.75